News
CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announces a strategic collaboration with Angoulême/Bordeaux- based Inside Therapeutics and Angers-based MiNT Laboratory to ...
Once upon a time, in a world that now feels as distant as a fairy tale, Queensland Health, in collaboration with three of the ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.
New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...
Using the gene scissors CRISPR and stem cells, researchers have managed to identify a common denominator for different gene mutations that all cause the neurological disease ALS. The research shows ...
Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...
15h
TheHealthSite on MSNCOVID-19 Cases Rising In India: Can Existing COVID Vaccines Protect You From The Deadly JN.1 Omicron Variant?COVID-19 Is Back! The JN.1 variant is spreading rapidly across Asia: How COVID vaccines have prevented the past variants and ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Shift Bioscience (Shift), a biotech company using an AI powered virtual cell to fight age-driven diseases, today announced the appointments of Lord David Prior as Chair of the Board and Sir Tony ...
A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, ...
Biomedical engineers at Georgia Tech created a treatment that could one day unlock a universal strategy for treating some of ...
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results